Health
RedHill presents positive Phase 2 results for oral opaganib in patients with COVID-19 pneumonia – News-Medical.Net
RedHill Biopharma Ltd., a specialty biopharmaceutical company, today announced presentation of the positive Phase 2 safety and…
RedHill Biopharma Ltd. (Nasdaq: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company, today announced presentation of the positive Phase 2 safety and efficacy data for oral opaganib (Yeliva®, ABC294640) in hospitalized patients with…
Continue Reading
-
Noosa News9 hours agoMan charged over allegedly abandoning Arnie the German shepherd in car after claiming dog and vehicle were stolen
-
Noosa News10 hours agoMotorcyclist dies in crash with truck
-
General24 hours agoARIA Awards 2025 winners: Amyl & The Sniffers and Ninajirachi dominate
-
General15 hours agoSmall-town cleaner finds himself in legal battle with EnduroShield over product packaging